257 related articles for article (PubMed ID: 28558380)
1. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
3. Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Zhang Y; Wang F; Ning N; Chen Q; Yang Z; Guo Y; Xu D; Zhang D; Zhan T; Cui W
Int J Cancer; 2015 Mar; 136(5):1228-33. PubMed ID: 25042121
[TBL] [Abstract][Full Text] [Related]
4. A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
Chen J; Wang H; Zhou L; Liu Z; Tan X
J Clin Lab Anal; 2022 May; 36(5):e24341. PubMed ID: 35334495
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
Sun B; Liu H; Wang S; Xiang J; Liu X
J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
[TBL] [Abstract][Full Text] [Related]
6. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
7. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
[No Abstract] [Full Text] [Related]
8. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.
Varillas JI; Zhang J; Chen K; Barnes II; Liu C; George TJ; Fan ZH
Theranostics; 2019; 9(5):1417-1425. PubMed ID: 30867841
[No Abstract] [Full Text] [Related]
11. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
[TBL] [Abstract][Full Text] [Related]
12. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
Vicente D; Lee AJ; Hall CS; Lucci A; Lee JE; Kim MP; Katz MHG; Hurd MW; Maitra A; Rhim Md AD; Tzeng CD
J Surg Res; 2019 Nov; 243():90-99. PubMed ID: 31170555
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
Sergeant G; van Eijsden R; Roskams T; Van Duppen V; Topal B
BMC Cancer; 2012 Nov; 12():527. PubMed ID: 23157946
[TBL] [Abstract][Full Text] [Related]
15. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.
Guo X; Lv X; Fang C; Lv X; Wang F; Wang D; Zhao J; Ma Y; Xue Y; Bai Q; Yao X; Chen Y
Int J Cancer; 2016 Oct; 139(8):1821-9. PubMed ID: 27281120
[TBL] [Abstract][Full Text] [Related]
16. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma.
Yang C; Liu Z; Zeng X; Wu Q; Liao X; Wang X; Han C; Yu T; Zhu G; Qin W; Peng T
Aging (Albany NY); 2019 Jun; 11(11):3679-3703. PubMed ID: 31182680
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.
Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592
[TBL] [Abstract][Full Text] [Related]
20. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]